$11.50 - 0.32 (-2.707%)

3 month stock price graph

4:00 PM ET on Feb 21, 2018 Pricing delayed 20 minutes

Investors & Media

Analyst Coverage

Dicerna Pharmaceuticals is covered by the following analysts.

Analyst Coverage
Firm Analyst
Gbola Amusa, MD
Ritu Baral
H.C. Wainwright & Co.
Ed Arce
Leerink Partners
Paul Matteis
Steve Willey

Please note that any opinions, estimates or forecasts regarding Dicerna Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Dicerna Pharmaceuticals or its management. Dicerna Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.